G. Faita et al.
1H, J=8.2, 2.0 Hz), 7.82 (d, 1H, J=5.2 Hz), 7.25 (m, 7H), 3.67 (dd, 1H,
J=8.0, 5.1 Hz), 2.16 (m, 2H), 1.74 (dt, 2H, J=9.9, 3.1 Hz), 1.63 (m, 2H),
1.41 (m, 2H), 1.04 (dq, 1H, J=12.7, 3.4 Hz), 0.06 ppm (s, 9H); 13C NMR
(CDCl3, 75 MHz): d=143.1, 141.0, 139.9, 139.6, 130.5, 126.5, 125.4, 124.5,
123.7, 122.5, 113.1, 99.1, 43.8, 39.9, 37.8, 26.9, 25.6, 22.4, 1.5 ppm; 10
(minor product): 1H NMR (CDCl3, 300 MHz): d=8.28 (d, 1H, J=
6.6 Hz), 7.87 (dd, 1H, J=8.0, 2.1 Hz), 7.69 (d, 1H, J=4.3 Hz), 7.1–7.3
(m, 7H), 3.53 (t, 1H, J=4.5 Hz), 2.14 (m, 2H), 1.8–1.2 (m, 7H), 0.95 (m,
1H), 0.06 ppm (s, 9H); chiral HPLC analysis on Chiralpak AD column:
eluent: isopropanol/hexane 10:90; flow rate: 1.0 mLminÀ1; tR: 8.9 (10),
9.4 ((+)-9), 15.3. (10), 33.5 min ((À)-9).
Reaction of 1a with (1,2-dihydronaphthalen-4-yloxy)trimethylsilane (11):
2-((4S,4aR,10bR)-4-Phenyl-10b-(trimethylsilyloxy)-4a,5,6,10b-tetrahydro-
4H-benzo[h]chromen-2-yl)pyridine-N-oxide ((À)-12a) was obtained by
column chromatography (eluent: ethyl acetate/cyclohexane 1:1) and re-
crystallised from ethyl acetate/ligroine as a white solid; m.p. 161–1638C;
[a]2D5 =À69.7 (c=0.4, CHCl3); 1H NMR (CDCl3, 300 MHz): d=8.40 (dd,
1H, J=6.5, 0.8 Hz), 8.15(dd, 1H, J=8.2, 2.0 Hz), 7.54 (dd, 1H, J=
7.8,0.8 Hz), 7.38 (d, 1H, J=2.6 Hz), 7.05–7.15 (m, 9H), 3.36 (dd, 1H, J=
10.7, 2.6 Hz), 3.08 (ddd, 1H, J=18.8, 10.5, 7.5 Hz), 2.93 (dd, 1H, J=18.8,
7.3 Hz), 2.36 (m, 2H), 1.77 (m, 1H), 0.12 ppm (s, 9H); 13C NMR (CDCl3,
75 MHz): d=142.5, 142.3, 141.1, 139.7, 136.8, 136.2, 128.8, 128.1, 127.8,
126.3, 125.7, 124.7, 124.4, 123.5, 122.8, 114.0, 99.8, 43.8, 40.5, 23.2, 19.2,
1.2 ppm; chiral HPLC analysis on Chiralpak AD column: eluent: isopro-
panol/hexane 10:90; flow rate: 1.0 mLminÀ1; tR: 7.0 ((+)-12a), 8.0 min
((À)-12a).
2-((S)-3-((R)-1-Oxo-1,2,3,4-tetrahydronaphthalen-2-yl)-3-phenylpropa-
noyl)pyridine-N-oxide ((+)-13a) was obtained by column chromatogra-
phy (eluent: ethyl acetate/cyclohexane 1:1) and recrystallised from ethyl
acetate/ligroine as a white solid; m.p. 147–1498C; [a]2D5 =25.3 (c=0.1,
CHCl3); 1H NMR (CDCl3, 300 MHz): d=8.16 (d, 1H, J=6.2 Hz), 8.00
(d, 1H, J=7.8 Hz), 7.47 (t, 1H, J=7.4 Hz), 7.34–7.16 (m, 10H), 4.13 (dt,
1H, J=11.9, 4.7 Hz), 3.82 (d, 2H, J=7.1 Hz), 3.03 (m, 1H), 2.86 (m,
2H), 2.14 (m, 1H), 1.67 ppm (m, 1H); 13C NMR (CDCl3, 75 MHz): d=
198.7, 195.9, 146.6, 143.1, 141.3, 139.7, 132.8, 132.1, 128.1, 127.84, 127.0,
127.0, 126.1, 126.1, 124.9, 51.8, 46.8, 38.7, 27.1, 25.4 ppm; chiral HPLC
analysis on Chiralpak AD column: eluent: isopropanol/hexane 10:90;
flow rate: 1.0 mLminÀ1; tR: 61.8 ((À)-13a), 65.8 min ((+)-13a).
2-((S)-3-(4-Bromophenyl)-3-((R)-1-oxo-1,2,3,4-tetrahydronaphthalen-2-
yl)-propanoyl)pyridine-N-oxide ((+)-13b) was obtained by column chro-
matography (eluent: ethyl acetate/cyclohexane 1:1); [a]2D5 =35.5 (c=0.8,
CHCl3); 1H NMR (CDCl3, 300 MHz): d=8.16 (d, 1H, J=6.0 Hz), 7.98
(d, 1H, J=7.8 Hz), 7.45–7.19 (m, 10H), 4.16 (dt, 1H, J=14.3, 7.0 Hz),
3.82 (dd, 2H, J=7.5, 2.7 Hz), 3.06–2.79 (m, 3H), 2.12 (m, 1H), 1.66 ppm
(m, 1H); 13C NMR (CDCl3, 75 MHz): d=198.1, 195.4, 146.3, 143.0, 140.3,
139.9, 132.8, 132.0, 130.8, 128.1, 127.2, 127.0, 126.3, 126.1, 125.0, 120.0,
51.6, 46.5, 38.0, 27.4, 25.2 ppm; chiral HPLC analysis on Chiralpak AD
column: isopropanol/hexane 20:80; flow rate: 1.0 mLminÀ1; tR: 30.9 ((À)-
13b), 34.6 min ((+)-13b).
2-((S)-3-(4-Bromophenyl)-3-((S)-1-oxo-1,2,3,4-tetrahydronaphthalen-2-
yl)-propanoyl)pyridine-N-oxide ((+)-14b) was obtained by column chro-
matography (eluent: ethyl acetate/cyclohexane 1:1); 1H NMR (CDCl3,
300 MHz): d=8.17 (d, 1H, J=6.5 Hz), 8.02 (d, 1H, J=7.0 Hz), 7.47–7.19
(m, 10H), 4.27 (dt, 1H, J=10.6, 4.0 Hz), 4.13 (m, 1H), 3.48 (dd, 1H, J=
17.6, 3.9 Hz), 2.98 (m, 2H), 2.81 (dt, 1H, J=12.1, 4.6 Hz), 2.15 ppm (m,
2H); 13C NMR (CDCl3, 75 MHz): d=197.6, 195.5, 146.1, 143.2, 141.1,
139.9, 132.9, 132.2, 130.9, 129.5, 128.1, 127.2, 127.0, 126.4, 126.2, 125.0,
119.8, 53.0, 42.7, 38.7, 28.5, 24.3 ppm; chiral HPLC analysis on Chiralpak
AD column: isopropanol/hexane 20:80; flow rate: 1.0 mLminÀ1; tR: 38.7
((+)-14b), 40.6 min ((À)-14b).
General method for a-tetralone (15) addition to 1a,b: In anhydrous
glassware, 2 (0.03mmol), copper triflate (0.010g, 0.03mmol) and pyri-
dine-N-oxide derivatives 1a,b (0.3mmol) were added to a test tube. The
reactants were dissolved in freshly dried dichloromethane (0.5mL) and
magnetically stirred at room temperature. After 15min, a-tetralone (15;
650 mL, 5mmol) was added to the tube. The reaction was monitored by
TLC and stopped after completion. The reaction mixture was quenched
in water and extracted with dichloromethane (3ꢃ10mL), and the organic
phase was dried over sodium sulphate. The products were isolated by
column chromatography with ethyl acetate/cyclohexane (3:7) as the
eluent. The 1H and 13C NMR spectra were identical to those found for
the products from the corresponding reaction with the enol silyl ether.
X-ray diffraction studies of 7a, 12a and 13a: All crystal structures were
solved by direct methods (SIR97)[20] and refined with full-matrix least-
Table 5. Crystallographic data for 7a, 12a and 13a.
2-((S)-3-((S)-1-Oxo-1,2,3,4-tetrahydronaphthalen-2-yl)-3-phe-
nylpropanoyl)pyridine-N-oxide ((+)-14a) was obtained by
column chromatography (eluent: ethyl acetate/cyclohexane
1:1); [a]2D5 =14.4 (c=0.1, CH3OH); 1H NMR (CDCl3,
300 MHz): d=8.17 (dd, 1H, J=6.5, 0.5 Hz), 8.03 (dd, 1H, J=
7.0, 0.5 Hz), 7.45 (dt, 1H, J=7.0, 0.5 Hz), 7.32–7.19 (m, 10H),
4.32 (dt, 1H, J=8.5, 4.2 Hz), 4.10 (dd, 1H, J=17.4, 10.6 Hz),
3.48 (dd, 1H, J=17.4, 4.3 Hz), 2.99 (m, 2H), 2.81 (m, 1H),
2.13 ppm (m, 2H); 13C NMR (CDCl3, 75 MHz): d=197.8,
195.9, 143.3, 142.0, 139.8, 132.8, 128.1, 127.8, 127.7, 127.0,
126.3, 126.1, 125.9, 124.9, 53.2, 42.6, 39.2, 28.5, 24.2 ppm; chiral
HPLC analysis on Chiralpak AD column: eluent: isopropanol/
7a
12a
13a
formula
Mr
crystal system
space group
a [ꢂ]
b [ꢂ]
c [ꢂ]
a [8]
b [8]
C18H15NO4
309.31
C27H29NO3Si
443.60
C24H21NO3
371.42
orthorhombic
P212121 (no. 19)
8.368(2)
17.598(3)
10.262(3)
90
monoclinic
P21 (no. 4)
9.752(2)
11.937(2)
10.409(1)
90
orthorhombic
P212121 (no. 19)
6.094(1)
15.840(2)
19.215(4)
90
90
90
100.91(1)
90
90
90
g [8]
hexane 10:90; flow rate: 1.0 mLminÀ1
; tR: 71.4 ((+)-14a),
V [ꢂ3]
Z
1511.2(6)
4
1189.8(3)
2
1854.7(6)
4
74.3 min ((À)-14a).
1calcd [gcmÀ3
]
1.360
1.238
1.330
Reaction of 1b with (1,2-dihydronaphthalen-4-yloxy)trimethyl-
silane (11): 2-((4S,4aR,10bR)-4-(4-Bromophenyl)-10b-(trime-
thylsilyloxy)-4a,5,6,10b-tetrahydro-4H-benzo[h]chromen-2-yl)-
pyridine-N-oxide ((À)-12b) was obtained by column chroma-
tography (eluent: ethyl acetate/cyclohexane 1:1); 1H NMR
(CDCl3, 300 MHz): d=8.24 (dd, 1H, J=6.5, 0.8 Hz), 8.14 (dd,
1H, J=8.2, 2.0 Hz), 7.52 (d, 1H, J=7.8 Hz), 7.47–7.36 (m,
4H), 7.28 (dt, 1H, J=7.7, 1.4 Hz), 7.21–7.14 (m, 5H), 3.31 (dd,
1H, J=10.9, 2.6 Hz), 3.1–2.8 (m, 2H), 2.33 (m, 2H), 1.70 (m,
1H), 0.10 ppm (s, 9H); 13C NMR (CDCl3, 75 MHz): d=144.4,
143.9, 143.3, 142.2, 138.8, 138.3, 133.4, 131.7, 131.0, 130.41,
128.0, 126.8, 126.6, 125.7, 125.1, 122.2, 115.3, 101.9, 46.0, 42.2,
25.3, 21.3, 3.4 ppm; chiral HPLC analysis on Chiralpak AD
column: isopropanol/hexane 10:90; flow rate: 1.0 mLminÀ1; tR:
8.2 ((+)-12b), 9.5 min ((À)-12b).
m (MoKa) [mmÀ1
2qmax [8]
]
0.097
0.127
0.088
25
30
30
min/max transmission
collected reflns
independent reflns
Rint
0.959/0.990
3601
0.948/0.990
8113
0.986/1.000
7144
2671
6927
3077
0.023
0.011
0.026
strong refln [Fo >2s(Fo)]
refined parameters
R1/wR2 (strong data)
R1/wR2 (all data)
goodness of fit
1925
5010
2233
208
292
253
0.0422/0.0928
0.0741/0.1082
0.962
0.0446/0.0926
0.0736/0.1045
1.019
0.0444/0.0942
0.0693/0.1040
1.017
max/min residuals [eꢂÀ3
Flackꢀs parameter
]
0.16/À0.16
0.21/À0.14
0.16/À0.20
n.d.[a]
À0.05(11)
n.d.[a]
[a] n.d.: not determined.
&
6
&
ꢁ 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 0000, 00, 0 – 0
ÝÝ
These are not the final page numbers!